Steve Connor: The reason we have to wait for useful results

Science Studies

Share
Related Topics

One in 10 experiments involving the use of laboratory monkeys serves no benefit whatsoever, whether to scientific understanding, medicine or animal welfare. This was probably the most striking conclusion to emerge from the Review of Research Using Non-Human Primates by a panel of experts led by the eminent Cambridge zoologist Professor Sir Patrick Bateson.

There was another finding in the report that should cause equal anxiety. The experts concluded that it was very difficult to detail the precise medical benefits accruing from the majority of studies involving monkeys that they had retrospectively investigated over a 10-year period between 1996 and 2006.

A possible reason for this, other than, of course, the uselessness of using monkeys, is the long time-lag between basic scientific discoveries and the practical applications that emerge from them. It may well be that 10 years is just not long enough to be able to witness the new treatments or cures that emerge from the particular primate experiments the panel investigated.

This is a familiar problem in science, especially medical science, which has the expectation of providing real benefits to patients, rather than merely a better understanding of the natural world. It can take many years, and sometimes decades before we reap the rewards of a scientific breakthrough, and it is often only with the benefit of hindsight that true breakthroughs can be distinguished from damp squibs.

Take for example the publication of the human genome 10 years ago. There were great expectations in 2001 that this complete map of the human genetic code would revolutionise medical treatment in the decades to come.

The hype did not just come from journalists like myself. President Bill Clinton called it the "most important, most wondrous map ever produced by mankind", while the then prime minister, Tony Blair, called it a "breakthrough that takes humankind across a frontier to a new era".

And it was not just the media and the politicians who got caught up in the excitement. I remember well the words of scientist Mike Dexter, the then head of the Wellcome Trust, which funded much of the Human Genome Project, who said at a press briefing that the completion of the genome would eclipse the significance of the Moon landings and even the invention of the wheel.

A decade or so ago it was not unusual to see predictions about the revolution in "personalised medicine" that would emerge from knowing the full three-billion-letter sequence of the human genome. We would go to our doctors with a computer read-out of our DNA and would be prescribed medicines specifically to suit our type of genes – a sort of bespoke medicine more in tune with Savile Row than Harley Street.

The reality is that although there are one or two such "genomic" drugs now available, they are incredibly expensive. The idea of a widespread, personalised approach to medicine looks laughable in the face of a cash-strapped NHService which has to ration operations for cataracts and varicose veins.

In his excellent review of the science coverage by the BBC, the geneticist Professor Steve Jones makes the point that journalists often tend to over-egg a scientific achievement in order to make it sound more important than perhaps it is. It can be done by simple phrases like "a penicillin moment" in otherwise factually sound and insightful broadcasts.

We are all guilty of this – journalists, politicians and, yes, scientists themselves. It is human nature. We want to transmit the excitement of discovery to a wider electorate, to convince a funding organisation that a piece of basic research will produce real benefits to society, and yes to tell a story in the most dramatic way we can without, hopefully, distorting the truth.

Unfortunately, in reality we cannot predict the true importance of a "breakthrough" with any certainty. Scientists try their best to fathom the unfathomable, but they are often no better than the rest of us when it comes to knowing whether anything truly worthwhile will come out of a piece of new science, however breathtaking.

Rarefied world of the double helix

Every day I pass the building site next to London's St Pancras Station that will be the Francis Crick Institute, formerly known as the UK Centre for Medical Research and Innovation. As the now-defunct title states, it is to become the pre-eminent place in Britain where advances in medical research are translated into practical benefits for society at large – the "innovation" bit.

Crick, along with Jim Watson and Maurice Wilkins, unravelled the three-dimensional structure of the DNA double helix. It was a bit of basic, fundamental science that would eventually result in untold practical benefits and a multibillion-pound biotechnology industry.

The publication of the structure in Nature in 1953 was barely noticed outside the rarefied world of these early molecular biologists. There were no satellite link-ups between US presidents and British prime ministers, no wall-to-wall coverage in the national press or in-depth television interviews. It was a different era, when scientists spoke to themselves, rather than the great unwashed public.

The building site is surrounded by a 20-foot wooden fence topped by razor wire presumably as a precaution against animal activists. A pity that the wood comes from Brazil (I saw the Brazilian stamps before they were painted over). I don't know what the institute's new director, Sir Paul Nurse, will make of that given his devotion to green causes.

s.connor@independent.co.uk

React Now

Latest stories from i100
Have you tried new the Independent Digital Edition apps?
iJobs Job Widget
iJobs General

Guru Careers: Software Developer / C# Developer

£40-50K: Guru Careers: We are seeking an experienced Software / C# Developer w...

Guru Careers: Software Developer

£35 - 40k + Benefits: Guru Careers: We are seeking a Software Developer (JavaS...

SThree: Trainee Recruitment Consultant / Resourcer

£18000 - £23000 per annum + Commission: SThree: As a Trainee Recruitment Consu...

Ashdown Group: UI Developer - (UI, HTML, CSS, JavaScript, AngularJS)

£25000 - £40000 per annum: Ashdown Group: UI Developer - (UI, JavaScript, HTML...

Day In a Page

 

In Sickness and in Health: 'I'm really happy to be alive and to see Rebecca'

Rebecca Armstrong
Abuse - and the hell that came afterwards

Abuse - and the hell that follows

James Rhodes on the extraordinary legal battle to publish his memoir
Why we need a 'tranquility map' of England, according to campaigners

It's oh so quiet!

The case for a 'tranquility map' of England
'Timeless fashion': It may be a paradox, but the industry loves it

'Timeless fashion'

It may be a paradox, but the industry loves it
If the West needs a bridge to the 'moderates' inside Isis, maybe we could have done with Osama bin Laden staying alive after all

Could have done with Osama bin Laden staying alive?

Robert Fisk on the Fountainheads of World Evil in 2011 - and 2015
New exhibition celebrates the evolution of swimwear

Evolution of swimwear

From bathing dresses in the twenties to modern bikinis
Sun, sex and an anthropological study: One British academic's summer of hell in Magaluf

Sun, sex and an anthropological study

One academic’s summer of hell in Magaluf
From Shakespeare to Rising Damp... to Vicious

Frances de la Tour's 50-year triumph

'Rising Damp' brought De la Tour such recognition that she could be forgiven if she'd never been able to move on. But at 70, she continues to flourish - and to beguile
'That Whitsun, I was late getting away...'

Ian McMillan on the Whitsun Weddings

This weekend is Whitsun, and while the festival may no longer resonate, Larkin's best-loved poem, lives on - along with the train journey at the heart of it
Kathryn Williams explores the works and influences of Sylvia Plath in a new light

Songs from the bell jar

Kathryn Williams explores the works and influences of Sylvia Plath
How one man's day in high heels showed him that Cannes must change its 'no flats' policy

One man's day in high heels

...showed him that Cannes must change its 'flats' policy
Is a quiet crusade to reform executive pay bearing fruit?

Is a quiet crusade to reform executive pay bearing fruit?

Dominic Rossi of Fidelity says his pressure on business to control rewards is working. But why aren’t other fund managers helping?
The King David Hotel gives precious work to Palestinians - unless peace talks are on

King David Hotel: Palestinians not included

The King David is special to Jerusalem. Nick Kochan checked in and discovered it has some special arrangements, too
More people moving from Australia to New Zealand than in the other direction for first time in 24 years

End of the Aussie brain drain

More people moving from Australia to New Zealand than in the other direction for first time in 24 years
Meditation is touted as a cure for mental instability but can it actually be bad for you?

Can meditation be bad for you?

Researching a mass murder, Dr Miguel Farias discovered that, far from bringing inner peace, meditation can leave devotees in pieces
Eurovision 2015: Australians will be cheering on their first-ever entrant this Saturday

Australia's first-ever Eurovision entrant

Australia, a nation of kitsch-worshippers, has always loved the Eurovision Song Contest. Maggie Alderson says it'll fit in fine